Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print January 3, 2008
DOI: 10.2337/db07-0389

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-0389v1
db07-0389v2
57/5/1216    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demozay, D.
Right arrow Articles by Van Obberghen, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demozay, D.
Right arrow Articles by Van Obberghen, E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

FALDH REVERSES THE DELETERIOUS ACTION OF OXIDATIVE STRESS INDUCED BY THE LIPID PEROXIDATION PRODUCT, HNE, ON INSULIN SIGNALING IN 3T3-L1 ADIPOCYTES.

Damien Demozay1, Jean-Christophe Mas1, Stephane Rocchi1, and Emmanuel Van Obberghen1

1Institut National de la Santé et de la Recherche Médicale (INSERM) U145, IFR 50, Faculté de Médecine, Université de Nice Sophia-Antipolis, 28 Avenue de Valombrose, 06107 Nice Cedex 2, France

Objective: Oxidative stress is associated with insulin resistance and is thought to contribute to progression towards type 2 diabetes. Oxidation induces cellular damages through increased amounts of reactive aldehydes from lipid peroxidation. The aim of our study was to investigate (i) the effect of the major lipid peroxidation end-product, 4-hydroxynonenal (HNE), on insulin signaling in 3T3-L1 adipocytes, and (ii) whether Fatty Aldehyde Dehydrogenase (FALDH), which detoxifies HNE, protects cells and improves insulin action under oxidative stress conditions.

Research Design and Methods: 3T3-L1 adipocytes were exposed to HNE and/or infected with control adenovirus or adenovirus expressing FALDH.

Results: Treatment of 3T3-L1 adipocytes with HNE at nontoxic concentrations leads to a pronounced decrease in IRS-1/-2 proteins and in insulin-induced IRS and IRβ tyrosine-phosphorylation. Remarkably, we detect increased binding of HNE to IRS-1/-2 generating HNE-IRS adducts, which likely impair IRS function and favor their degradation. PI3-kinase and PKB activities are also downregulated upon HNE treatment resulting in blunted metabolic responses. Moreover, FALDH, by reducing adduct formation, partially restores HNE-generated decrease in insulin-induced IRS-1 tyrosine-phosphorylation and metabolic responses. Moreover, rosiglitazone could have an antioxidant effect as it blocks the noxious HNE action on IRS-1 by increasing FALDH gene expression. Collectively, our data show that FALDH improves insulin action in HNE-treated 3T3-L1 adipocytes.

Conclusion: Oxidative stress induced by reactive aldehydes, such as HNE, is implicated in the development of insulin resistance in 3T3-L1 adipocytes, which is alleviated by FALDH. Hence, detoxifying enzymes could play a crucial role in blocking progression of insulin resistance to diabetes.


Correspondence: Emmanuel.VAN-OBBERGHEN{at}unice.fr


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.